Ka rerekē te wā totoka noa o te tinana tangata i runga i te tikanga kimi.
Anei ētahi tikanga kimi noa me ō rātou awhe tohutoro noa:
1 Te wā thromboplastin wāhanga whakahohe (APTT):
Ko te awhe tohutoro noa ko te 25-37 hēkona. Ko te APTT e whakaata ana i te mahi a ngā āhuatanga toto toto VIII, IX, XI, XII, me ētahi atu i roto i te ara toto toto o roto.
2 Te wā Prothrombin (PT):
Ko te uara tohutoro noa ko te 11-13 hēkona. Ko te PT te mea nui e whakamahia ana hei aromatawai i te mahi a ngā āhuatanga toto toto II, V, VII, X, me ētahi atu i roto i te ara toto toto o waho.
3 Te ōwehenga ā-ao kua whakapūmautia (INR):
Ko te awhe tohutoro noa kei waenga i te 0.8 me te 1.2. Ka tatauhia te INR i runga i te uara PT, ā, ka whakamahia hei aroturuki i te pānga rongoā o ngā rongoā ārai toto ā-waha (pēnei i te warfarin) kia rite ai ngā hua whakamātautau i waenga i ngā taiwhanga rerekē.
4 Fibrinogen (FIB):
Ko te awhe tohutoro noa ko te 2-4g/L. Ko te FIB he glycoprotein plasma e hangaia ana e te ate, ā, he mahi nui tāna i roto i te tukanga toto totoka. Ka hurihia hei fibrin i raro i te mahi a te thrombin hei hanga i te toto totoka.
Me mōhio he rerekē pea ngā taputapu whakamātautau me ngā matū o ngā taiwhanga rerekē, ā, he rerekē pea ngā uara tohutoro noa. Hei tāpiri, ka pāngia hoki te wā totohu e ētahi āhuatanga ā-tinana (pēnei i te tau, te ira tangata, te haputanga, me ētahi atu) me ngā āhuatanga mate (pēnei i te mate ate, ngā mate pūnaha toto, te tango i ētahi rongoā, me ētahi atu). Nō reira, i te wā e whakamārama ana i ngā hua o te wā totohu, me whakahaere he tātaritanga whānui me te āhuatanga motuhake o te tūroro.
TE HANGARAU WHAKAMUTUNGA O BEIJING INC.
RATONGA KUPU WHAKAKŪTURU TAUTOKOTANGA WHAKAPUTAPUTA
TE TONO MŌ NGĀ RŌPŪ KAIĀWHINA
Kua roa a Beijing Succeeder Technology Inc. (waehere hea: 688338) e whai wāhi nui ana ki te mara o te tātaritanga toto toto mai i tōna whakatūnga i te tau 2003, ā, e whakapau kaha ana ki te noho hei kaiārahi i tēnei mara. Kei Beijing te tari matua, ā, he kaha te tīma R&D, whakaputa me te hoko a te kamupene, e arotahi ana ki te auahatanga me te whakamahi i te hangarau tātaritanga toto toto me te hemostasis.
Nā tōna kaha hangarau tino pai, kua toa a Succeeder i ngā mana pateni whai mana e 45, tae atu ki ngā mana pateni hanga hou e 14, ngā mana pateni tauira whaipainga e 16 me ngā mana pateni hoahoa e 15. E 32 hoki ngā tiwhikete rēhita hua taputapu hauora Akomanga II a te kamupene, e 3 ngā tiwhikete tuku Akomanga I, me te tiwhikete EU CE mō ngā hua e 14, ā, kua paahitia e ia te tiwhikete pūnaha whakahaere kounga ISO 13485 hei whakarite i te hiranga me te pumau o te kounga hua.
Ehara i te mea ko Succeeder anake te hinonga matua o te Beijing Biomedicine Industry Leapfrog Development Project (G20), engari i angitu hoki tana whakaurunga ki te Science and Technology Innovation Board i te tau 2020, ā, i eke ki te whanaketanga tere o te kamupene. I tēnei wā, kua hangaia e te kamupene he whatunga hokohoko ā-motu e kapi ana i ngā rau o ngā kaihoko me ngā tari. He pai te hoko o ana hua i te nuinga o ngā wāhi o te whenua. Kei te kaha hoki tana whakawhānui i ngā mākete o tāwāhi, me te whakapai tonu i tana whakataetae ā-ao.
Kāri pakihi
WeChat Hainamana